0001225208-12-003240.txt : 20120207 0001225208-12-003240.hdr.sgml : 20120207 20120207175343 ACCESSION NUMBER: 0001225208-12-003240 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120203 FILED AS OF DATE: 20120207 DATE AS OF CHANGE: 20120207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beasley Jim C CENTRAL INDEX KEY: 0001463423 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 12579071 MAIL ADDRESS: STREET 1: C/O C. R. BARD, INC. STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0304 4 2012-02-03 0000009892 BARD C R INC /NJ/ BCR 0001463423 Beasley Jim C C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 Group Vice President Common Stock 2012-02-03 4 M 0 8090.0000 66.7950 A 56082.0000 D Common Stock 2012-02-03 4 S 0 9149.0000 93.2468 D 46933.0000 D Common Stock 8382.3510 I 401(k) Plan Option (Right to Buy) 66.7950 2012-02-03 4 M 0 8090.0000 0.0000 D 2015-07-13 Common Stock 8090.0000 0.0000 D Represents the weighted average sales price for price increments ranging from $93.10 to $93.33. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Options fully vested in accordance with schedule upon achievement of certain performance criteria. Myra McGinley, Attorney-in-Fact 2012-02-07